These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 21884437)
1. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Kim HR; Cheon SH; Rha SY; Lee S; Han KH; Chon CY; Lee JD; Sung JS; Chung HC Asia Pac J Clin Oncol; 2011 Sep; 7(3):258-69. PubMed ID: 21884437 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Zou WL; Zang YJ; Chen XG; Shen ZY Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Scatton O; Zalinski S; Terris B; Lefevre JH; Casali A; Massault PP; Conti F; Calmus Y; Soubrane O Liver Transpl; 2008 Jun; 14(6):779-88. PubMed ID: 18508370 [TBL] [Abstract][Full Text] [Related]
6. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Hu RH; Ho MC; Wu YM; Yu SC; Lee PH Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552 [TBL] [Abstract][Full Text] [Related]
7. Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation. Lee JO; Kim DY; Lim JH; Seo MD; Yi HG; Oh DY; Im SA; Kim TY; Bang YJ J Gastroenterol Hepatol; 2009 May; 24(5):800-5. PubMed ID: 19175825 [TBL] [Abstract][Full Text] [Related]
8. Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection. Shim JH; Kim KM; Lee YJ; Ko GY; Yoon HK; Sung KB; Park KM; Lee SG; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ Ann Surg Oncol; 2010 Mar; 17(3):869-77. PubMed ID: 20033326 [TBL] [Abstract][Full Text] [Related]
9. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection. Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934 [TBL] [Abstract][Full Text] [Related]
10. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Island ER; Pomposelli J; Pomfret EA; Gordon FD; Lewis WD; Jenkins RL Arch Surg; 2005 Apr; 140(4):353-8. PubMed ID: 15837885 [TBL] [Abstract][Full Text] [Related]
11. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Grasso A; Stigliano R; Morisco F; Martines H; Quaglia A; Dhillon AP; Patch D; Davidson BR; Rolles K; Burroughs AK Transplantation; 2006 Jun; 81(11):1532-41. PubMed ID: 16770242 [TBL] [Abstract][Full Text] [Related]
12. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. Lee KK; Kim DG; Moon IS; Lee MD; Park JH J Surg Oncol; 2010 Jan; 101(1):47-53. PubMed ID: 19798686 [TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284 [TBL] [Abstract][Full Text] [Related]
14. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309 [TBL] [Abstract][Full Text] [Related]
15. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences]. Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of hepatocellular carcinoma after liver transplantation]. Zhou LX; Yan LN Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771 [TBL] [Abstract][Full Text] [Related]
18. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539 [TBL] [Abstract][Full Text] [Related]
19. Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation? Kim JM; Kwon CH; Joh JW; Kim SJ; Shin M; Kim EY; Moon JI; Jung GO; Choi GS; Lee SK Transplant Proc; 2010 Apr; 42(3):821-4. PubMed ID: 20430181 [TBL] [Abstract][Full Text] [Related]